Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

T-DM1 demonstrated a manageable safety profile, and the adverse events were consistent with those reported in randomized trials. The data are not yet sufficient to allow for a formal analysis of RFS and OS, and long-term follow-up is required.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2024-12-07
DOI
https://doi.org/10.3390/cancers16234104
Citations
2
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

Teresa Arcuri, Loretta D’Onofrio, Giuseppe Sanguineti, Laura Pizzuti et al.
2 citations
Cancers
HER2/EGFR in Cancer Research
0.57
article

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

Teresa Arcuri, Loretta D’Onofrio, Giuseppe Sanguineti, Laura Pizzuti, Francesco Pantano, Patrizia Vici, Nicola D’Ostilio, Tatiana D’Angelo, Antonella Roselli, Maria Rosaria Valerio, Antonino Grassadonia, Alberto Fulvi, Fabio Pelle, Fabio Calabrò, Lorena Filomeno, Ilaria Puccica, Rossana Berardi, Claudio Botti, Luca I. Moscetti, Francesca Ferranti, Agnese Fabbri, Andrea Botticelli, Katia Cannita, Nicola Tinari, Emilio Bria, Simona Gasparro, Ida Paris, Monica Giordano, Martina Nunzi, Teresa Gamucci, Azzurra Irelli, Luca Visani, Paolo Marchetti, Sonia Cappelli, Raffaella Palumbo, Eriseld Krasniqi, Gennaro Ciliberto, Francesco Pavese, Andrea Torchia, Francesca Sofia Di Lisa, Giuseppe Tonini, Marco Mazzotta, G. Ferretti, Giovanna Garufi, Giuliana D’Auria, Maddalena Barba, Simonetta Chiara Stani, Valentina Sini, Amedeo Villanucci, Isabella Sperduti, Flavia Cavicchi, Mirco Pistelli, Rosalinda Rossi, Rosa Saltarelli, Matteo Vergati, Anna Cariello, Ramy Kayal, Claudia Cutigni, Elena Fiorio, Filippo Greco, Icro Meattini, Costanza De Rossi, Jacopo Scialino, Mauro Minelli, Antonio Astone, Jennifer Foglietta, Mimma Raffaele, Lorenzo Livi
article en
2 citations

Abstract

T-DM1 demonstrated a manageable safety profile, and the adverse events were consistent with those reported in randomized trials. The data are not yet sufficient to allow for a formal analysis of RFS and OS, and long-term follow-up is required.

CancersVol. 16(23)
Università Cattolica del Sacro Cuore (IT), University of Verona (IT), Marche Polytechnic University (IT), Azienda Ospedaliera San Giovanni Addolorata (IT), Policlinico Umberto I (IT), Agostino Gemelli University Polyclinic (IT), University of Chieti-Pescara (IT), Istituti Clinici Scientifici Maugeri (IT), Ospedale di Santo Spirito (IT), Azienda Unità Sanitaria Locale Della Romagna (IT), Fatebenefratelli Hospital (IT), Azienda Ospedaliero-Universitaria di Modena (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Ospedale Santa Maria (IT), Istituto Dermopatico dell'Immacolata (IT), Azienda Socio Sanitaria Territoriale Lariana (IT), Ospedale di Belcolle (IT), Ospedale Sandro Pertini (IT), Campus Bio Medico University Hospital (IT), Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale "Floraspe Renzetti" (IT), University of Florence (IT), Sapienza University of Rome (IT)
Ministero della Salute
Good health and well-being
Openalex Percentile: Top 26%
HER2/EGFR in Cancer Research
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.